A Placebo-Controlled Trial of Bupropion Combined with Nicotine Patch for Smoking Cessation in Schizophrenia

BACKGROUND: Schizophrenics smoke at higher rates (58-88%) than the general population (~22%), and have great difficulty with quitting smoking. We determined if the combination of sustained-release (SR) bupropion (BUP) with transdermal nicotine patch (TNP) is well-tolerated, and superior to placebo (...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: George, Tony P., Vessicchio, Jennifer C., Sacco, Kristi A., Weinberger, Andrea H., Dudas, Melissa M., Allen, Taryn M., Creeden, Cerissa L., Potenza, Marc N., Feingold, Alan, Jatlow, Peter I.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2007
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC2693008/
https://ncbi.nlm.nih.gov/pubmed/18096137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biopsych.2007.11.002
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन